Trinity College Dublin
Trinity College Dublin is Ireland’s highest-ranked university, a public research university founded in 1592 in the heart of Dublin, offering a wide range of programs in arts, humanities, law, business, engineering, science, and health sciences.
Trinity College Dublin’s commitment within TEN4CARE is provided by the Trinity Translational Medicine Institute (TTMI). TTMI vision is to advance biomedical research that transforms scientific discoveries into real-world healthcare solutions.
TTMI in conjunction with the University Hospital partners (St. James’s Hospital), spearheads the integration of basic biomedical and clinical research. TTMI is a globally recognised leader in translational medicine, and also nanotechnology based medical devices, across Ireland and beyond.
The Laboratory for Biological Characterisation of Advanced Materials (LBCAM) focus is to accelerate the translation of nanotechnology-enabled discoveries from laboratory bench to patient bedside through interdisciplinary research, education, and strategic partnerships. LBCAM has extensive multidisciplinary collaborative national and international projects in translational nanotechnology applied to medicine and medical technology which are driving innovation to transforms healthcare and improves patient outcomes.
LBCAM at TCD-TTMI with the awarded funding will be involved in several work packages from direct collaborative research actions (WP1, WP3, WP5, WP7, WP8) and also as WP4 leader of the physico-chemical characterisation of full 4D nanocomposite fibrous hydrogel and each component. The LBCAM at TCD-TTMI will support the identification of key exploitable results in WP10 as part of the exploitation activity and also in the dissemination and communication of publishable results as part of the project stakeholder engagement (WP10, WP11, WP12).
